// App-Quantinova.ai

P157 : Distinct differences in complement perturbation between scleroderma-related interstitial lung disease with and without emphysema

Researchers

Presenter

  • Claire Beesley

Principal Investigators

  • Alice Cole

  • Nina Goldman

  • Joseph Barnett

  • David Abraham

  • Christopher Denton

  • Rizgar Mageed

  • Voon Ong

Medical Centers

  • UCL Centre for Nephrology, London, United Kingdom

  • William Harvey Research Institute, London, United Kingdom

  • Department of Virology, Royal Free Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

Disease

  • Interstitial lung disease

  • Scleroderma

  • Chronic obstructive pulmonary disease

Biomarkers

  • Complement 3

  • Complement Component 5a

  • Mannan-binding lectin-associated serine protease 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved